These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21856154)

  • 1. New betulinic acid derivatives as potent proteasome inhibitors.
    Qian K; Kim SY; Hung HY; Huang L; Chen CH; Lee KH
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5944-7. PubMed ID: 21856154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and inhibition of the proteasome by betulinic acid and its derivatives.
    Huang L; Ho P; Chen CH
    FEBS Lett; 2007 Oct; 581(25):4955-9. PubMed ID: 17904555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
    Liu JH; Tang J; Zhu ZF; Chen L
    J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia.
    Waechter F; da Silva GNS; Willig JB; de Oliveira CB; Vieira BD; Trivella DBB; Zimmer AR; Buffon A; Pilger DA; Gnoatto SCB
    Anticancer Agents Med Chem; 2017; 17(13):1777-1785. PubMed ID: 28403779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
    Shi W; Tang N; Yan WD
    J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
    Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
    Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
    Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
    Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.
    Santos RC; Salvador JA; Marín S; Cascante M; Moreira JN; Dinis TC
    Bioorg Med Chem; 2010 Jun; 18(12):4385-96. PubMed ID: 20494586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.
    Wei H; Guo J; Sun X; Gou W; Ning H; Fang Z; Liu Q; Hou W; Li Y
    Eur J Med Chem; 2022 Jan; 227():113918. PubMed ID: 34688014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of betulinic acid derivatives with activity against human melanoma.
    Kim DS; Pezzuto JM; Pisha E
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulinic acid and its derivatives: a patent review (2008-2013).
    Csuk R
    Expert Opin Ther Pat; 2014 Aug; 24(8):913-23. PubMed ID: 24909232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
    Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
    Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
    Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
    Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity.
    Santos RC; Salvador JA; Marín S; Cascante M
    Bioorg Med Chem; 2009 Sep; 17(17):6241-50. PubMed ID: 19674909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ursolic and betulinic derivatives as potential cytotoxic agents.
    Baglin I; Poumaroux A; Nour M; Tan K; Mitaine-Offer AC; Lacaille-Dubois MA; Chauffert B; Cavé C
    J Enzyme Inhib Med Chem; 2003 Apr; 18(2):111-7. PubMed ID: 12943194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
    Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betulinic acid and its derivatives as anti-angiogenic agents.
    Mukherjee R; Jaggi M; Rajendran P; Siddiqui MJ; Srivastava SK; Vardhan A; Burman AC
    Bioorg Med Chem Lett; 2004 May; 14(9):2181-4. PubMed ID: 15081004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity of novel betulinic acid and betulin derivatives.
    Kommera H; Kaluderović GN; Kalbitz J; Paschke R
    Arch Pharm (Weinheim); 2010 Aug; 343(8):449-57. PubMed ID: 20726008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
    Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
    Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
    Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
    Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.